Lysosomal Protein Transmembrane 4 beta (LAPTM4B) Peptide
-
- Target See all LAPTM4B products
- LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YPNSIQEYIR QLPPNFPYRD DVMSVNPTCL VLIILLFISI ILTFKGYLIS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LAPTM4 B antibody,
Alternative Names: LAPTM4B control peptide, LAPTM4B antibody Blocking Peptide, Anti-LAPTM4B Blocking Peptide, Lysosomal Associated Protein Transmembrane 4 Beta Blocking Peptide, LAPTM4beta Blocking Peptide, LC27 Blocking Peptide, LAPTM4B, LAPTMB-4, LAPTMB 4, LAPTMB-4 Blocking Peptide, LAPTMB 4 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))
- Synonyms
- LAPTM4beta Peptide, LC27 Peptide, C330023P13Rik Peptide, lysosomal protein transmembrane 4 beta Peptide, lysosomal-associated protein transmembrane 4B Peptide, LAPTM4B Peptide, Laptm4b Peptide
- Background
- LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.
- Molecular Weight
- 35 kDa
-